These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17103172)

  • 1. Evaluation of quality of life using ASQoL questionnaire in patients with ankylosing spondylitis in a Chinese population.
    Zhao LK; Liao ZT; Li CH; Li TW; Wu J; Lin Q; Huang F; Yu DT; Gu JR
    Rheumatol Int; 2007 May; 27(7):605-11. PubMed ID: 17103172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility of the Bath Ankylosing Spondylitis Indices of disease activity (BASDAI), functional status (BASFI) and overall well-being (BAS-G) in anti-tumour necrosis factor-treated spondyloarthropathy patients.
    Madsen OR; Rytter A; Hansen LB; Suetta C; Egsmose C
    Clin Rheumatol; 2010 Aug; 29(8):849-54. PubMed ID: 20306214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients.
    Lin Z; Gu J; He P; Gao J; Zuo X; Ye Z; Shao F; Zhan F; Lin J; Li L; Wei Y; Xu M; Liao Z; Lin Q
    Rheumatol Int; 2011 Feb; 31(2):233-8. PubMed ID: 20012866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Ankylosing Spondylitis Quality of Life questionnaire: responsiveness of a new patient-reported outcome measure.
    Packham JC; Jordan KP; Haywood KL; Garratt AM; Healey EL
    Rheumatology (Oxford); 2012 Apr; 51(4):707-14. PubMed ID: 22179735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better short-term clinical response to etanercept in Chinese than Caucasian patients with active ankylosing spondylitis.
    Chou CT; Tsai CY; Liang TH; Chang TM; Lai CH; Wei CC; Chen KH; Lin SC; Yu CL; Liou LB; Luo SF; Lee CS; Hsue YT; Huang CM; Chen JH; Lai NS; Cheng HH; Cheng TT; Lai HM; Tsai WC; Yen JH; Lu LY; Chang CP
    Mod Rheumatol; 2010 Dec; 20(6):580-7. PubMed ID: 20683633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the reliability of Persian version of ankylosing spondylitis quality of life (ASQoL) questionnaire and related clinical and demographic parameters in patients with ankylosing spondylitis.
    Fallahi S; Jamshidi AR; Bidad K; Qorbani M; Mahmoudi M
    Rheumatol Int; 2014 Jun; 34(6):803-9. PubMed ID: 24170319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and related variables in patients with ankylosing spondylitis.
    Bodur H; Ataman S; Rezvani A; Buğdaycı DS; Cevik R; Birtane M; Akıncı A; Altay Z; Günaydın R; Yener M; Koçyiğit H; Duruöz T; Yazgan P; Cakar E; Aydın G; Hepgüler S; Altan L; Kırnap M; Olmez N; Soydemir R; Kozanoğlu E; Bal A; Sivrioğlu K; Karkucak M; Günendi Z
    Qual Life Res; 2011 May; 20(4):543-9. PubMed ID: 20978859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
    McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
    Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire.
    Duruöz MT; Doward L; Turan Y; Cerrahoglu L; Yurtkuran M; Calis M; Tas N; Ozgocmen S; Yoleri O; Durmaz B; Oncel S; Tuncer T; Sendur O; Birtane M; Tuzun F; Bingol U; Kirnap M; Celik Erturk G; Ardicoglu O; Memis A; Atamaz F; Kizil R; Kacar C; Gurer G; Uzunca K; Sari H
    Rheumatol Int; 2013 Nov; 33(11):2717-22. PubMed ID: 23765201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum metalloproteinase-3 levels in assessing efficacy of Etanercept in patients with ankylosing spondylitis].
    Wang QH; Zhang SZ; Xue J; Wu HX
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 39(4):409-14. PubMed ID: 20731042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept in the longterm treatment of patients with ankylosing spondylitis.
    Dijkmans B; Emery P; Hakala M; Leirisalo-Repo M; Mola EM; Paolozzi L; Salvarani C; Sanmarti R; Sibilia J; Sieper J; Van Den Bosch F; van der Heijde D; van der Linden S; Wajdula J
    J Rheumatol; 2009 Jun; 36(6):1256-64. PubMed ID: 19411393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
    Brandt J; Listing J; Haibel H; Sörensen H; Schwebig A; Rudwaleit M; Sieper J; Braun J
    Rheumatology (Oxford); 2005 Mar; 44(3):342-8. PubMed ID: 15561737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in Turkish patients with ankylosing spondylitis: impact of peripheral involvement on quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning.
    Yılmaz O; Tutoğlu A; Garip Y; Ozcan E; Bodur H
    Rheumatol Int; 2013 May; 33(5):1159-63. PubMed ID: 22955799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
    Brandt J; Khariouzov A; Listing J; Haibel H; Sörensen H; Grassnickel L; Rudwaleit M; Sieper J; Braun J
    Arthritis Rheum; 2003 Jun; 48(6):1667-75. PubMed ID: 12794835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The validity and reliability of quality of life questionnaires in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and meta-analysis.
    He Q; Luo J; Chen J; Yang J; Yao C; Xu C; Tao Q
    Health Qual Life Outcomes; 2022 Jul; 20(1):116. PubMed ID: 35907948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-Related Quality of Life in Patients with Ankylosing Spondylitis: Relationship with Disease-Related Variables.
    Elolemy G; Aboughanima A; Ganeb S; Elziat H
    Curr Rheumatol Rev; 2020; 16(4):311-318. PubMed ID: 31656154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1).
    Deodhar AA; Dougados M; Baeten DL; Cheng-Chung Wei J; Geusens P; Readie A; Richards HB; Martin R; Porter B
    Arthritis Rheumatol; 2016 Dec; 68(12):2901-2910. PubMed ID: 27390130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab.
    van der Heijde D; Breban M; Halter D; DiVittorio G; Bratt J; Cantini F; Kary S; Pangan AL; Kupper H; Rathmann SS; Sieper J; Mease PJ
    Rheumatology (Oxford); 2015 Jul; 54(7):1210-9. PubMed ID: 25541333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment efficacy of etanercept and MTX combination therapy for ankylosing spondylitis hip joint lesion in Chinese population.
    Lian F; Yang X; Liang L; Xu H; Zhan Z; Qiu Q; Ye Y
    Rheumatol Int; 2012 Jun; 32(6):1663-7. PubMed ID: 21387110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy.
    Davis JC; van der Heijde D; Dougados M; Woolley JM
    Arthritis Rheum; 2005 Aug; 53(4):494-501. PubMed ID: 16082640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.